| 00548-5601-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00548-5602-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00548-5603-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00548-5604-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00548-5605-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00548-5606-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00548-5607-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 1 × 10 | 15 | 150 | $74.55 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00548-5608-00 | Enoxaparin SodiumAmphastar Pharmaceuticals, Inc. | 3 × 1 | 30 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 60505-0792-04 | Enoxaparin SodiumApotex Corp | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 60505-0794-04 | Enoxaparin SodiumApotex Corp | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q4 2022 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 60505-0795-04 | Enoxaparin SodiumApotex Corp | 1 × 10 | 10 | 100 | $49.70 | ASP | Q4 2022 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 60505-0796-04 | Enoxaparin SodiumApotex Corp | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q4 2022 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 60505-0798-04 | Enoxaparin SodiumApotex Corp | 1 × 10 | 15 | 150 | $74.55 | ASP | Q4 2022 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71839-0109-10 | Enoxaparin SodiumBE Pharmaceuticals Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71839-0110-10 | Enoxaparin SodiumBE Pharmaceuticals Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71839-0111-10 | Enoxaparin SodiumBE Pharmaceuticals Inc. | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71839-0112-10 | Enoxaparin SodiumBE Pharmaceuticals Inc. | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71839-0113-10 | Enoxaparin SodiumBE Pharmaceuticals Inc. | 1 × 10 | 10 | 100 | $49.70 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71839-0115-10 | Enoxaparin SodiumBE Pharmaceuticals Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71839-0116-10 | Enoxaparin SodiumBE Pharmaceuticals Inc. | 1 × 10 | 15 | 150 | $74.55 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0457-42 | Enoxaparin SodiumBluePoint Laboratories | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2024 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 68001-0458-42 | Enoxaparin SodiumBluePoint Laboratories | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0459-42 | Enoxaparin SodiumBluePoint Laboratories | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2024 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 68001-0460-42 | Enoxaparin SodiumBluePoint Laboratories | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2024 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 68001-0461-42 | Enoxaparin SodiumBluePoint Laboratories | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2024 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 68001-0462-42 | Enoxaparin SodiumBluePoint Laboratories | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2024 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 68001-0463-42 | Enoxaparin SodiumBluePoint Laboratories | 1 × 10 | 15 | 150 | $74.55 | ASP | Q1 2024 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 68001-0464-41 | Enoxaparin SodiumBluePoint Laboratories | 3 × 1 | 30 | 30 | $14.91 | ASP | Q1 2024 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 68001-0633-42 | Enoxaparin SodiumBluePoint Laboratories | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q4 2025 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0634-42 | Enoxaparin SodiumBluePoint Laboratories | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q4 2025 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0635-42 | Enoxaparin SodiumBluePoint Laboratories | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q4 2025 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0636-42 | Enoxaparin SodiumBluePoint Laboratories | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q4 2025 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0637-42 | Enoxaparin SodiumBluePoint Laboratories | 1 × 10 | 10 | 100 | $49.70 | ASP | Q4 2025 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0638-42 | Enoxaparin SodiumBluePoint Laboratories | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q4 2025 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0639-42 | Enoxaparin SodiumBluePoint Laboratories | 1 × 10 | 15 | 150 | $74.55 | ASP | Q4 2025 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 68001-0641-41 | Enoxaparin SodiumBluePoint Laboratories | 3 × 1 | 30 | 30 | $14.91 | ASP | Q1 2026 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72572-0280-10 | Enoxaparin SodiumCivica, Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q3 2026 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0531-90 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0531-98 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0533-83 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0533-93 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0535-87 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0535-98 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0539-03 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 3 × 1 | 30 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0559-65 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q4 2022 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0559-93 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0564-65 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0564-97 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0566-65 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q3 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0566-98 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0584-65 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q4 2022 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0584-99 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0586-65 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q3 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0586-96 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0589-94 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 1 × 10 | 15 | 150 | $74.55 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0605-84 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0605-94 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0607-88 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0607-98 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 63323-0655-99 | Enoxaparin SodiumFreseniUS Kabi USA, LLC | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 81952-0123-23 | Enoxaparin SodiumHepalink USA, Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 81952-0124-24 | Enoxaparin SodiumHepalink USA, Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 81952-0126-26 | Enoxaparin SodiumHepalink USA, Inc. | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 81952-0128-28 | Enoxaparin SodiumHepalink USA, Inc. | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 81952-0130-06 | Enoxaparin SodiumHepalink USA, Inc. | 1 × 10 | 10 | 100 | $49.70 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 81952-0132-28 | Enoxaparin SodiumHepalink USA, Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 81952-0135-06 | Enoxaparin SodiumHepalink USA, Inc. | 1 × 10 | 15 | 150 | $74.55 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0410-81 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q3 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71288-0410-83 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q3 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71288-0410-85 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q3 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71288-0410-87 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q3 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71288-0410-89 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 1 × 10 | 10 | 100 | $49.70 | ASP | Q3 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71288-0411-81 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q3 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71288-0411-83 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 1 × 10 | 15 | 150 | $74.55 | ASP | Q3 2023 – Q4 2026 | Excluded listingEnoxaparin Sodium |
|---|
| 71288-0426-03 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 3 × 1 | 30 | 30 | $14.91 | ASP | Q3 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0426-91 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 3 × 1 | 30 | 30 | $14.91 | ASP | Q4 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0432-81 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0432-92 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0433-83 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0433-92 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0434-85 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0434-92 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0435-87 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0435-92 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0436-89 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 1 × 10 | 10 | 100 | $49.70 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0436-92 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 1 × 10 | 10 | 100 | $49.70 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0437-92 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0437-94 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0438-94 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 1 × 10 | 15 | 150 | $74.55 | ASP | Q4 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 71288-0438-96 | Enoxaparin SodiumMeitheal Pharmaceuticals Inc. | 1 × 10 | 15 | 150 | $74.55 | ASP | Q4 2023 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 16714-0006-10 | Enoxaparin SodiumNorthstar RxLLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 16714-0016-10 | Enoxaparin SodiumNorthstar RxLLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 16714-0026-10 | Enoxaparin SodiumNorthstar RxLLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 16714-0036-10 | Enoxaparin SodiumNorthstar RxLLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 16714-0046-10 | Enoxaparin SodiumNorthstar RxLLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 16714-0056-10 | Enoxaparin SodiumNorthstar RxLLC | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 16714-0066-10 | Enoxaparin SodiumNorthstar RxLLC | 1 × 10 | 15 | 150 | $74.55 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72603-0165-10 | Enoxaparin SodiumNorthstar RxLLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72603-0175-10 | Enoxaparin SodiumNorthstar RxLLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72603-0185-10 | Enoxaparin SodiumNorthstar RxLLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72603-0195-10 | Enoxaparin SodiumNorthstar RxLLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72603-0205-10 | Enoxaparin SodiumNorthstar RxLLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72603-0215-10 | Enoxaparin SodiumNorthstar RxLLC | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 72603-0225-10 | Enoxaparin SodiumNorthstar RxLLC | 1 × 10 | 15 | 150 | $74.55 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 25021-0410-70 | Enoxaparin SodiumSagent Pharmaceuticals | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 25021-0410-71 | Enoxaparin SodiumSagent Pharmaceuticals | 1 × 10 | 10 | 100 | $49.70 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 25021-0410-76 | Enoxaparin SodiumSagent Pharmaceuticals | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 25021-0410-77 | Enoxaparin SodiumSagent Pharmaceuticals | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 25021-0410-78 | Enoxaparin SodiumSagent Pharmaceuticals | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 25021-0411-70 | Enoxaparin SodiumSagent Pharmaceuticals | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 25021-0411-71 | Enoxaparin SodiumSagent Pharmaceuticals | 1 × 10 | 15 | 150 | $74.55 | ASP | Q2 2024 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00781-3238-63 | Enoxaparin SodiumSandoz Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q3 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00781-3246-64 | Enoxaparin SodiumSandoz Inc. | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q3 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00781-3256-66 | Enoxaparin SodiumSandoz Inc. | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q3 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00781-3262-68 | Enoxaparin SodiumSandoz Inc. | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q3 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00781-3268-69 | Enoxaparin SodiumSandoz Inc. | 1 × 10 | 10 | 100 | $49.70 | ASP | Q3 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00781-3298-68 | Enoxaparin SodiumSandoz Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q4 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00781-3299-69 | Enoxaparin SodiumSandoz Inc. | 1 × 10 | 15 | 150 | $74.55 | ASP | Q3 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00075-0620-40 | LovenoxSanofi-Aventis U.S. LLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-0621-60 | LovenoxSanofi-Aventis U.S. LLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-0622-80 | LovenoxSanofi-Aventis U.S. LLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-0623-00 | LovenoxSanofi-Aventis U.S. LLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-0624-30 | LovenoxSanofi-Aventis U.S. LLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-0626-03 | LovenoxSanofi-Aventis U.S. LLC | 3 × 1 | 30 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-2912-01 | LovenoxSanofi-Aventis U.S. LLC | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-2915-01 | LovenoxSanofi-Aventis U.S. LLC | 1 × 10 | 15 | 150 | $74.55 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8013-10 | LovenoxSanofi-Aventis U.S. LLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8014-10 | LovenoxSanofi-Aventis U.S. LLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8016-10 | LovenoxSanofi-Aventis U.S. LLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8018-10 | LovenoxSanofi-Aventis U.S. LLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8020-10 | LovenoxSanofi-Aventis U.S. LLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8022-10 | LovenoxSanofi-Aventis U.S. LLC | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8025-10 | LovenoxSanofi-Aventis U.S. LLC | 1 × 10 | 15 | 150 | $74.55 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00075-8030-01 | LovenoxSanofi-Aventis U.S. LLC | 3 × 1 | 30 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedLovenox |
|---|
| 00955-1003-10 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00955-1004-10 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 0.4 × 10 | 4 | 40 | $19.88 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00955-1006-10 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 0.6 × 10 | 6 | 60 | $29.82 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00955-1008-10 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 0.8 × 10 | 8 | 80 | $39.76 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00955-1010-10 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 1 × 10 | 10 | 100 | $49.70 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00955-1012-10 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00955-1015-10 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 1 × 10 | 15 | 150 | $74.55 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 00955-1016-01 | Enoxaparin SodiumSanofi-Aventis U.S. LLC | 3 × 1 | 30 | 30 | $14.91 | ASP | Q1 2021 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 70710-1757-06 | Enoxaparin SodiumZydus Pharmaceuticals (USA) Inc. | 0.3 × 10 | 3 | 30 | $14.91 | ASP | Q1 2022 – Q4 2026 | ListedEnoxaparin Sodium |
|---|
| 70710-1762-06 | Enoxaparin SodiumZydus Pharmaceuticals (USA) Inc. | 0.8 × 10 | 12 | 120 | $59.64 | ASP | Q1 2022 – Q4 2026 | ListedEnoxaparin Sodium |
|---|